Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection

Title
Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
Authors
Keywords
-
Journal
MOLECULAR MEDICINE
Volume 27, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-21
DOI
10.1186/s10020-021-00422-z

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now